Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com
It intends to use the net proceeds of the offering, which includes a $1.44 million up-size option, for R&D studies, patent and legal costs, and general working capital purposes Under the scheme, Lexaria is offering 1,828,571 units, with each unit consisting of one share and one warrant to purchase one share at US$5.25 per unit Lexaria Bioscienc
RAD is being introduced in response to consumer demand for more affordable cannabis concentrate offerings RAD products have been shipped into Alberta and British Columbia and are expected to be sent to other Canadian provinces and territories soon Heritage Cannabis Holdings Corp () () (FRA:2UE) reported the launch of a new Premium 5 brand RAD, in c
Roilty’, its consumer-focused Cannabis 2.0 product, will be positioned as a high-end, accessible mainstream brand Namaste Technologies says it sees increasing demand for additional Cannabis 2.0 products with a strong value proposition  () () (FRA:M5BQ) announced that it has launched its Cannabis 2.0, consumer-focused recreational house brand, ‘Roil
IntelGenx expects to make its first shipment of the filmstrip products to Heritage Cannabis in 2Q 2021 Heritage Cannabis says it continues to build a wide spectrum of medical cannabis products that offer both traditional and newer delivery platforms Heritage Cannabis Holdings Corp () () announced that it has placed its first purchase order with Int
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires PyroGenesis Canada Inc () (OTCQB:NYRNF) CEO Peter Pascali will present at the SNN Network Canada virtual event on Thursday January 7 at 10:30am ET. To access the live presentation, viewers may visit https://www.webcaster4.com/Webcast/Page/2059/39297. Inves
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Wellness Inc (), a leading US health and wellness CBD company, announced that it has completed its initial public offering (IPO) to raise US$17 million and has started trading on the big board in Toronto. The company rounded out its US$17 million IPO by of
Green Therapeutics is an award-winning, Nevada-based cannabis company with a strong brand portfolio of high-end dried flower and designer/luxury derivative products; ALPS is a global leader in facility design, construction management and (post) commissioning services to the horticultural sector Terry Booth, currently a principal of ALPS, will becom
1933 Industries (CSE: TGIF- OTCQB: TGIFF) CEO Paul Rosen joined Steve Darling from Proactive with news the company has released their Q-1 financials which saw an increase in revenue of 12%. Rosen also talked about the company’s margins which also saw a massive increase. Rosen also shared his thoughts on 2021 and how the recent U.S. election may hav
Innocan Pharma (CSE: INNO- OTCPINK: INNPF) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has launched a new consumer website for the sale of their products. The site is shop.innocanpharma.com Bincovich also told Proactive about their recent closing of their financing as they added 2.3 million dollars into the treasury
The site will allow consumers to browse smoothly through its premium CBD-infused derma cosmetic product collection InnoCan Pharma founder CEO Iris Bincovich said this is a 'great opportunity for Innocan to start with B2C operations that will secure a new and sustainable source of income' Corporation () (OTCMKTS:INNPF) (FRA:IP4) on Tuesday unveiled
"We are pleased to have closed this offering so quickly and with only a few investors,” Canntab CEO Larry Lotowsky said in a statement The debentures are convertible at $0.80 per share and bear a two-year maturity date Canntab Therapeutics Limited () (OTCQB:CTABF) announced Thursday it had closed a non-brokered private placement of convertible debe
"We are pleased to have closed this offering so quickly and with only a few investors,” Canntab CEO Larry Lotowsky said in a statement The debentures are convertible at $0.80 per share and bear a two-year maturity date Canntab Therapeutics Limited () (OTCQB:CTABF) announced Thursday it had closed a non-brokered private placement of convertible debe